SKYE Trademark

Trademark Overview


On Tuesday, July 23, 2013, a trademark application was filed for SKYE with the United States Patent and Trademark Office. The USPTO has given the SKYE trademark a serial number of 86017949. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, June 14, 2024. This trademark is owned by Skye Biologics Inc.. The SKYE trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
skye

General Information


Serial Number86017949
Word MarkSKYE
Filing DateTuesday, July 23, 2013
Status800 - REGISTERED AND RENEWED
Status DateFriday, June 14, 2024
Registration Number4501163
Registration DateTuesday, March 25, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements


Description of MarkThe mark consists of the term "SKYE" in capital letters and a design comprising the letter "S" formed by 8 round globules that have grown together symbolizing the connectivity achieved by cells, proteins, and other components within the human body.
Goods and ServicesHuman allograft tissue
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 29, 2013
Primary Code005
First Use Anywhere DateSunday, January 1, 2012
First Use In Commerce DateSunday, January 1, 2012

Trademark Owner History


Party NameSkye Biologics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEl Segundo, CA 90245

Party NameSkye Biologics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressManhattan Beach, CA 90266

Party NameSkye Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressManhattan Beach, CA 90266

Trademark Events


Event DateEvent Description
Friday, July 26, 2013NEW APPLICATION ENTERED
Monday, July 29, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 30, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 5, 2013ASSIGNED TO EXAMINER
Thursday, November 7, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, November 7, 2013EXAMINERS AMENDMENT E-MAILED
Thursday, November 7, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 7, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, November 7, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2013ASSIGNED TO LIE
Wednesday, December 4, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, March 16, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 25, 2014REGISTERED-PRINCIPAL REGISTER
Monday, May 16, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 16, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 16, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 26, 2020TEAS SECTION 8 & 15 RECEIVED
Friday, May 22, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 22, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 22, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 25, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, March 11, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, June 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 14, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, June 14, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, June 14, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords


skye tissue allograft human